Siemens expands adaptive radiation therapy global reach
Three cancer centers have deployed Siemens Healthcare’s Artiste solution, an accelerator engineered for adaptive radiation therapy.
Dozens of patients have been treated to date at Maastro Clinic in the Netherlands, German Cancer Research Center in Heidelberg, Germany, and Baton Rouge General's Pennington Cancer Center in Louisiana, the company noted.
Siemens said that Artiste is an integrated imaging and workflow solution that offers a portfolio of image-guided and treatment delivery protocols, including in-room CT imaging capabilities and a new multileaf collimator, 160 MLC.
To ensure the therapeutic dose is delivered precisely to the target, and healthy tissue is spared as planned, it is necessary to image the patient just prior to treatment, verify that the patient position is correct, and adapt to any anatomical changes immediately before, or even during, treatment, Siemens said.
Dozens of patients have been treated to date at Maastro Clinic in the Netherlands, German Cancer Research Center in Heidelberg, Germany, and Baton Rouge General's Pennington Cancer Center in Louisiana, the company noted.
Siemens said that Artiste is an integrated imaging and workflow solution that offers a portfolio of image-guided and treatment delivery protocols, including in-room CT imaging capabilities and a new multileaf collimator, 160 MLC.
To ensure the therapeutic dose is delivered precisely to the target, and healthy tissue is spared as planned, it is necessary to image the patient just prior to treatment, verify that the patient position is correct, and adapt to any anatomical changes immediately before, or even during, treatment, Siemens said.